Apellis Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Apellis Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q2 2024.
  • Apellis Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 122M shares, a 3.49% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 122M +4.11M +3.49% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 121M +5.09M +4.38% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 120M +8.78M +7.93% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 118M +7.88M +7.14% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 118M +10.7M +10.1% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 116M +9.74M +9.15% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 111M +13.2M +13.6% Dec 31, 2022 10-K/A 2024-02-29
Q3 2022 110M +23.3M +26.7% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 107M +25.9M +32% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 106M +26M +32.3% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 97.5M +21.4M +28.1% Dec 31, 2021 10-K 2023-02-21
Q3 2021 87.2M +11.5M +15.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 81M +5.36M +7.09% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 80.4M +5.04M +6.68% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 76.1M +12.2M +19.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 75.7M +11.8M +18.5% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 75.6M +11.9M +18.7% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 75.4M +12.2M +19.3% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 63.9M +7.66M +13.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 63.9M +7.63M +13.6% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 63.7M +7.52M +13.4% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 63.2M +12.8M +25.4% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 56.3M +5.95M +11.8% Dec 31, 2018 10-K 2020-02-27
Q3 2018 56.2M +47.8M +564% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 56.2M Jun 30, 2018 10-Q 2018-07-31
Q1 2018 50.4M Mar 31, 2018 10-Q 2018-04-30
Q4 2017 50.3M +41.9M +497% Dec 31, 2017 10-K 2019-02-26
Q3 2017 8.47M Sep 30, 2017 10-Q 2017-12-20
Q4 2016 8.43M Dec 31, 2016 10-K 2018-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.